IL103411A0 - Pharmaceutical formulation for controlled release of melatonin - Google Patents

Pharmaceutical formulation for controlled release of melatonin

Info

Publication number
IL103411A0
IL103411A0 IL103411A IL10341192A IL103411A0 IL 103411 A0 IL103411 A0 IL 103411A0 IL 103411 A IL103411 A IL 103411A IL 10341192 A IL10341192 A IL 10341192A IL 103411 A0 IL103411 A0 IL 103411A0
Authority
IL
Israel
Prior art keywords
melatonin
controlled release
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
IL103411A
Other versions
IL103411A (en
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11064108&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL103411(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Priority to IL10341192A priority Critical patent/IL103411A/en
Priority to IL115861A priority patent/IL115861A/en
Publication of IL103411A0 publication Critical patent/IL103411A0/en
Publication of IL103411A publication Critical patent/IL103411A/en

Links

IL10341192A 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans IL103411A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL10341192A IL103411A (en) 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans
IL115861A IL115861A (en) 1992-10-11 1992-10-14 Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10341192A IL103411A (en) 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans

Publications (2)

Publication Number Publication Date
IL103411A0 true IL103411A0 (en) 1993-05-13
IL103411A IL103411A (en) 1996-11-14

Family

ID=11064108

Family Applications (2)

Application Number Title Priority Date Filing Date
IL10341192A IL103411A (en) 1992-10-11 1992-10-11 Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans
IL115861A IL115861A (en) 1992-10-11 1992-10-14 Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL115861A IL115861A (en) 1992-10-11 1992-10-14 Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome

Country Status (1)

Country Link
IL (2) IL103411A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144900A (en) 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments
CN104840439B (en) * 2014-02-17 2019-07-23 中国科学院上海药物研究所 A kind of bionical drug release preparation of epiphysin and preparation method thereof

Also Published As

Publication number Publication date
IL115861A (en) 1997-04-15
IL103411A (en) 1996-11-14

Similar Documents

Publication Publication Date Title
EP0741580A4 (en) Controlled release of pharmaceutically active substances for immunotherapy
ZA937483B (en) Process for the preparation of drug pellets
IL102591A0 (en) Compositions for the sustained and controlled release of medicaments and their preparation
ZA894020B (en) Controlled release pharmaceutical formulation
ZA93975B (en) Benzimidazolyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them
IL103593A0 (en) Controlled release pharmaceutical compositions
HU9300536D0 (en) Compounds of medical effect
HU9301700D0 (en) Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance
HUT69712A (en) Process for preparing benzimidazole derivatives and pharmaceutical compositions containing them
GB9204354D0 (en) Compounds for medicinal use
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
IL101410A0 (en) Formulation for the treatment of cancer
ZA93529B (en) Benzimidazoles pharmaceutical compositions containing these compounds and processes for preparing them
HU9301840D0 (en) Method for producing 4-hydroxi-phenyl-thio derivatives and pharmaceutical preparatives containing said compounds as active substance
GB9200415D0 (en) Inactivation of cytotoxic drugs
IL103411A0 (en) Pharmaceutical formulation for controlled release of melatonin
PL310821A1 (en) Aluminium containing pharmaceutical preparation of controllable active substance release
GB9304745D0 (en) Use of pharmaceutical formulations
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
HU9301580D0 (en) Phenyl-furoxanes and methods for producing said compounds and pharmaceutical preparatives containing them
IL115861A0 (en) Pharmaceutical formulation for controlled release of melatonin
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL105779A0 (en) Methods for the preparation of oxazole derivatives
GB9304549D0 (en) Apparatus for administration of drugs
ZA945651B (en) Use of benzenesulphonzlindole derivatives for the preparation of medicines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
PEL Intention of commissioner to extend period of protection
EXTG Extension of patent term granted

Extension date: 20170422